Edding Genor Group Holdings Limited (HKG:6998)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.120
-0.060 (-1.89%)
Apr 29, 2026, 4:08 PM HKT
49.28%
Market Cap 6.33B
Revenue (ttm) 2.77B
Net Income (ttm) 444.30M
Shares Out 1.99B
EPS (ttm) 0.26
PE Ratio 12.16
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,034,000
Average Volume 3,891,075
Open 3.210
Previous Close 3.180
Day's Range 3.100 - 3.250
52-Week Range 2.020 - 5.600
Beta 0.85
RSI 51.58
Earnings Date Mar 27, 2026

About HKG:6998

Edding Genor Group Holdings Limited, together with its subsidiaries, engages in the research, development, manufacturing, and distribution of biopharmaceutical products in China, the United States, and internationally. The company offers GB491, a differentiated CDK4/6 inhibitor for advanced or metastatic breast cancer; GB261, a novel CD3/CD20 bispecific antibody which is in clinical development for autoimmune diseases; and GB263T and GB268, tri-specific antibody candidates which are in preclinical and early clinical stages. It also provides Van... [Read more]

Sector Healthcare
Founded 2001
Employees 1,545
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6998
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.